×
Please click
here
if you are not redirected within a few seconds.
All
Images
News
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Mallinckrodt Acquires Questcor, to Join S&P 500 As Well
Yahoo Movies Canada
Mallinckrodt announced the completion of its acquisition of Questcor Pharmaceuticals, Inc. in a deal valued at approximately $5.8 billion.
2 weeks ago
Acura reports successful results from Nexafed clinical study
European Pharmaceutical Review
Acura has announced preliminary results from a clinical study which demonstrated bioequivalence of one formulation of NEXAFED tablets to...
109 months ago
Acura Pharmaceuticals Launches Next Generation Cold Medicine To Aid In The Fight Against Meth
Pharmaceutical Online
Thermo Fisher Scientific Inc., the world leader in serving science, introduces a new application note that demonstrates a fast and reliable...
137 months ago
Acura Pharmaceuticals introduces PSE product that will be less attractive to 'meth cooks'
Drug Store News
PALATINE, Ill. — Acura Pharmaceuticals in December will launch an immediate-release pseudoephedrine tablet under the brand name Nexafed that...
138 months ago
Acura Pharmaceuticals and AD Pharma Amend License to LIMITx™ LTX-03
Yahoo Finance
Amendment Extends NDA Acceptance DatePALATINE, Ill., March 01, 2022 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR) today...
26 months ago
Acura Pharmaceuticals Launches Meth-Resistant Pseudoephedrine, Nexafed
Forbes
Nexafed, a misuse-deterrent formulation of the nasal decongestant, pseudoephedrine. Credit: Acura Pharmaceuticals.
137 months ago
Acura pays Pfizer $2m to buy back anti-abuse tech and Oxecta drug
outsourcing-pharma.com
Acura has reacquired the rights to its opioid abuse-deterrent technology from Pfizer and is looking for pharma partners to relaunch its...
121 months ago
Acura settles Oxecta/Aversion patent litigation with Ranbaxy
Life Sciences Intellectual Property Review
Editor's picks. Biotechnology. BioNTech's patent counsel on fostering groundbreaking innovation. 2 May 2024...
120 months ago
Palatine Pharmaceutical Company Sues Over Painkiller | Palatine, IL Patch
Patch
Acura Pharmaceuticals claims India-based Ranbaxy Laboratories is wrongly planning to create a generic of Acura's Oxecta, according to the...
132 months ago
Company says new drug may be answer to meth problem
The Register-Herald
Smurfers know the difference when they scour the drug stores in hopes of making multiple purchases of common cold and allergy products and...
128 months ago